Last reviewed · How we verify

NCT04405960

Role of Alphacalcidol Supplement to Reduce Pain and COMP in Geriatric Knee Osteoarthritis Patients

Completed Phase 3 Last updated 28 May 2020
What this trial tests

Phase 3 trial testing Alfacalcidol 1 MCG Oral Capsule in Osteoarthritis, Knee in 146 participants. Completed in 31 December 2017.

Timeline
1 July 2017
Primary endpoint
30 September 2017
31 December 2017

Quick facts

Lead sponsorSyarif Hidayatullah State Islamic University Jakarta
PhasePhase 3
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment146
Start date1 July 2017
Primary completion30 September 2017
Estimated completion31 December 2017
Sites1 location across Indonesia

Drugs / interventions tested

Conditions studied

Sponsor

Syarif Hidayatullah State Islamic University Jakarta

Who can join

Adults 60 to 80, any sex, with Osteoarthritis, Knee or Aged. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Indonesian population's life expectancy has been increasing steadily in the last 3 decades. It potentially increases the prevalence of degenerative diseases, including osteoarthritis (OA). Serum Vitamin D (25(OH)D) level has been recognized as a risk factors for knee OA. Cartilage Oligomeric Matrix Protein (COMP) is cartilage degradation product can be used as a diagnostic marker for knee OA. This study aims to determine the effect of Vitamin D supplementation (Alphacalcidol) on pain based on WOMAC indicators and joint cartilage condition based on COMP serum markers in knee OA elderly patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Alfacalcidol 1 MCG Oral Capsule

Trials testing the same drug.

Other recruiting trials for Osteoarthritis, Knee

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04405960.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing